ABIVAX - ABVX Total Company Value
The Enterprise Value price trend for ABIVAX (ABVX) is 7406.84. The business relies on bringing a key treatment for intestinal inflammation to market as it completes final testing. A high barrier to entry is driven by strict FDA oversight and colossal R&D costs, although ABIVAX is accelerating progress through licensing deals and alliances with leading scientific centers.
Abivax Pharma (ABVX) - metric breakdowns and financial figures
- stock price and consensus target price:
- issuer market value details:
- business book valuation details:
- company total debt and liquidity indicators:
- earnings and valuation multiples indicators:
Analysis of all company metrics:abivax.com
Enterprise value reflects the total acquisition cost of a business, summing market capitalization and net debt to determine the buyer's actual expenditure. By analyzing the dynamics of the total company value, an investor can see the market consensus on ABIVAX (ABVX), where the current valuation is based on the patent potential of molecules prior to their final FDA approval and the establishment of a sustainable economic moat.
Competitors of ABIVAX (ABVX)
argenx N.V. - Total Company Value|BNTX: Real Price to Acquire Entire Company|ADMA: Total Company Value|PTGX (Protagonist Therapeutics) - Real Price to Acquire Entire Company|Business Value IMVT|Total Company Value Kiniksa|Grifols SA - Full Business Value|Enterprise Value ADPT|CLDX (Celldex Corp) - Value Adjusted for Debt and Cash|Enterprise Value AUPH (Aurinia Pharmaceuticals)|Enterprise Value biocryst.com BCRX|VERA - Total Company Value|Value Adjusted for Debt and Cash DNTH (Dianthus Therapeutics Inc)|Pharvaris Corp (PHVS) - Total Company Value|Real Price to Acquire Entire Company AbCellera Biologics Inc.|TRML (Tourmaline Bio, Inc.) - Enterprise Value|Enterprise Value precigen.com|Real Price to Acquire Entire Company PHAR (Pharming Group)|NKTR (Nektar Therapeutics Inc) - Value Adjusted for Debt and Cash|Enterprise Value UPB (Upstream Bio Corp)|Company Buyout Price Zenas Corp (ZBIO)|IMNM - Total Company Value|gossamerbio.com (GOSS) - Real Price to Acquire Entire Company|KalVista Pharmaceuticals, Inc. (KALV) - Total Company Value|Real Price to Acquire Entire Company Septerna, Inc.|Real Price to Acquire Entire Company PVLA|Enterprise Value Savara Pharma|Total Company Value Rigel Pharmaceuticals (RIGL)|anaptysbio.com - Business Value|Enterprise Value ATXS (Astria Therapeutics, Inc.)|enGene Holdings Inc (ENGN) - Total Enterprise Value|RAPT Therapeutics - Enterprise Value|JBIO - Enterprise Value|ACRS: Enterprise Value|KYTX (kyvernatx.com) - Total Company Value|TLSA (Tiziana Life Sciences Ltd) - Enterprise Value|Cabaletta Bio Inc. (CABA) - Company Buyout Price|Real Price to Acquire Entire Company VTYX (Ventyx Bio)|Total Company Value THTX (Theratechnologies, Inc)|Enterprise Value AVTX (Avalo Therapeutics, Inc)|Enterprise Value eledon.com ELDN|AGEN: Real Price to Acquire Entire Company|CLYM (Climb Bio Inc.) - Business Value|ZURA: Enterprise Value|aTyr Pharmaceuticals (ATYR) - Enterprise Value|ADAG (Adagene Inc) - Enterprise Value|Total Company Value IMA|Real Price to Acquire Entire Company STTK (Shattuck Labs, Inc.)|Total Company Value EQ (equilliumbio.com)|Connect Biopharma Holdings Limited - Real Price to Acquire Entire Company|IMUX: Business Value|ATRA - Total Company Value|Full Business Value IFRX|XFOR: Enterprise Value|Adicet Bio, Inc. - Value Adjusted for Debt and Cash|CELU (Celularity Inc) - Enterprise Value|Enterprise Value INmune Bio Corporation|Total Company Value Barinthus Biotherapeutics (BRNS)|KZR (kezarlifesciences.com) - Value Adjusted for Debt and Cash|Total Company Value SAB Biotherapeutics, Inc. SABS|AKTX - Real Price to Acquire Entire Company|Enlivex Therapeutics, Ltd. - Enterprise Value|QTTB - Enterprise Value|GOVX (GeoVax Labs, Inc.) - Real Price to Acquire Entire Company|edesabiotech.com - Value Adjusted for Debt and Cash|IBIO (iBio) - Enterprise Value|Carisma Tx (CARM) - Company Buyout Price|Total Company Value XTL Biopharmaceuticals, Ltd. (XTLB)|Real Price to Acquire Entire Company boltbio.com BOLT|Total Company Value HCW Biologics HCWB|APVO - Real Price to Acquire Entire Company|AIM: Real Price to Acquire Entire Company|ADTX - Enterprise Value|GRI Bio Corp (GRI) - Total Company Value|Business Value XRTX|HIND (Vyome Holdings Inc) - Enterprise Value|Total Enterprise Value revbiosciences.com REVB|Enterprise Value INDP|Enterprise Value Scinai Immunotherapeutics Ltd (SCNI)|Enterprise Value CALI (CalciMedica)|Affimed NV - Total Company Value|Allakos Therapeutics - Enterprise Value|Company Buyout Price HOOKIPA Pharma Inc. HOOK|IGMS (igmbio.com) - Real Price to Acquire Entire Company|ITOS (iTeos Therapeutics Inc) - Total Company Value|OCEA (Ocean Bio) - Enterprise Value|Enterprise Value TC BioPharm Ltd|Real Price to Acquire Entire Company THRD (Third Harmonic Bio)